Menu
Your Cart

Apostle MagTouch 3000 Large Volume Nucleic Acid Extraction Automation System

Apostle MagTouch 3000 Large Volume Nucleic Acid Extraction Automation System
Apostle MagTouch 3000 Large Volume Nucleic Acid Extraction Automation System
Apostle MagTouch 3000 Large Volume Nucleic Acid Extraction Automation System
Apostle MagTouch 3000 Large Volume Nucleic Acid Extraction Automation System
Secured Shopping
Best security features
Apostle MagTouch 3000 Large Volume Nucleic Acid Extraction Automation System

For convenient and fast extraction and purification of nucleic acids from large volume of liquid biological samples,  for example plasma, serum, urine, etc.

  1. Large Volume: world's first large volume nucleic acid extraction automation system that is capable of processing up to 6-10 mL of liquid biological samples in one single well.  Eliminate the needs to split samples into 2 mL aliquots like the traditional small-volume and semi-automated systems require
  2. Fully Automated and Fast: One button start; Requires no human intervention during the run; Standard run time is approximately 2 hours per 24 large-volume samples.
  3. 24 Independent Channels: Can process 1 to 24 large-volume samples simultaneously.  Both high-throughput and flexible.  
  4. High Efficiency and Low Cost: Guaranteed 50% improved efficiency and reduced cost, compared with the traditional small-volume and semi-automated systems. 
  5. Safer: Integrated with a UV light for unit interior disinfection. 


The Apostle MagTouch 3000 Nucleic Acids Extraction Automation System can be utilized with the Apostle MiniMax High Efficiency Cell-Free DNA Isolation Kit to automate the cfDNA isolation process, and significantly improve the lab flow and efficiency.

  • Cat # A202402-24


$46,000.00
A new clinical study, led by scientists from MD Anderson Cancer Center and published in Cancer Cell (journal impact factor = 50.3), shows that tumor and cfDNA methylation can be used to identify SCLC subtypes and might guide precision SCLC therapy. Apostle MiniMax cfDNA kit is one of the critical commercial assays listed in this article. Congratulations to this clinical research team. To date, the Apostle MiniMax technology has been used in 2 articles published in Nature Communications, 2 in Nature Medicine, 1 in Science Translational Medicine, 1 in PNAS, and over 60 scientific articles by over 60 international research and clinical teams in different journals.